ArticlePloS one2025
Adjusted trajectory of medication exposure taking into account the periodicity of dispensations and the number of dispensed packs and comparative analysis on EFEMERIS database.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We presented an adjustment method for the calculation of medication exposure trajectories based on the number of dispensed packs and the type of dispensations (occasional or regular). A comparative study based on the EFEMERIS data was carried out using three different scenarios of trajectory calculation depending on whether or not the number of packs and the periodicity of medication dispensations were taken into account. The impact of the scenario was highlighted using global indicators on the number of Define-Daily Dose (DDD) on all women exposed; the study of changes in individual trajectories from one scenario to another was carried out; we also compared the results of a clustering into four groups. If 65% of the trajectories remained unchanged, we could observe on the rest significant changes in number of DDD and/or on individual exposure profile. We observed 4% of trajectories that were attributed to a different cluster, and the clustering was of better quality with the adjustment method. Depending on the study context, an impact on cluster distribution could be observed for some maternal characteristics and neonatal outcomes. This was the case for a higher occurrence of neonatal pathology for neonates from mothers belonging to the cluster with high doses of psychotropics, thus reinforcing the conclusions of previous studies of a link between high exposure to psychotropic medications and presence of pathology for the newborn.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.